Distribution and Tissue Binding
Distribution is the pharmacokinetic phase in which a drug, once in the systemic circulation, moves reversibly between blood and the tissues of the body. How far and how fast a drug distributes is governed by blood flow, the permeability of biological membranes and barriers, and the extent to which the drug binds to plasma proteins and to tissue components. This area gathers the core concepts that describe where a drug goes after it reaches the blood and what determines the balance between bound and free drug.
Definition
Distribution and tissue binding refers to the reversible transfer of a drug between the bloodstream and the tissues, together with the protein- and tissue-binding equilibria that determine the fraction of drug that is free (pharmacologically available) versus bound at any time.
Scope
The area covers the determinants of drug distribution and the binding interactions that shape it: passage across specialised barriers such as the blood-brain barrier, reversible binding to plasma proteins, the volume of distribution as a summary parameter relating amount in the body to plasma concentration, and the partitioning of drug into specific tissues. It is a reference and educational grouping within pharmacokinetics and does not provide dosing or treatment guidance.
Sub-topics
Core questions
- What physiological and physicochemical factors determine how widely a drug distributes in the body?
- How do plasma-protein and tissue binding partition a drug between bound and free pools?
- How does the volume of distribution summarise the relationship between dose, plasma concentration, and the amount of drug in the body?
- Why do specialised barriers such as the blood-brain barrier restrict access of many drugs to particular compartments?
Key concepts
- Distribution phase
- Plasma protein binding (bound vs free drug)
- Tissue binding and partitioning
- Volume of distribution
- Blood-brain barrier and tissue barriers
- Perfusion- versus permeability-limited distribution
- Tissue:plasma partition coefficient
Mechanisms
After absorption, a drug is carried in blood and exchanges with tissues across capillary walls and cell membranes. The rate of exchange depends on regional blood flow (perfusion-limited tissues equilibrate quickly) and on membrane permeability (permeability-limited tissues equilibrate slowly), while the extent of distribution depends on binding. Drug bound to plasma proteins such as albumin and alpha-1-acid glycoprotein is retained in the circulation, whereas binding to tissue constituents draws drug out of plasma; only the unbound (free) drug crosses membranes and interacts with targets. The balance of these binding equilibria, together with lipophilicity, determines the apparent volume of distribution and the tissue:plasma partition coefficients that physiologically based models use to describe where drug accumulates.
Clinical relevance
Distribution concepts underpin the interpretation of plasma drug concentrations and explain why some drugs reach the central nervous system or other compartments while others do not. Understanding bound-versus-free drug and the volume of distribution is part of evidence appraisal and therapeutic-monitoring literacy in the health sciences. This entry is descriptive and educational and is not a basis for individual dosing or treatment decisions.
Evidence & guidelines
The concepts in this area are established in pharmacokinetic textbooks and reviews rather than in clinical trials; the volume of distribution and protein-binding framework is standard in regulatory and modelling practice for characterising new drugs.
History
The quantitative description of distribution grew out of compartmental pharmacokinetics in the mid-twentieth century, with the volume of distribution and protein-binding concepts becoming standard tools for characterising drug disposition. Later work extended these ideas into physiologically based models that predict tissue partitioning from drug properties and tissue composition.
Debates
- How clinically important are changes in plasma protein binding?
- A long-standing view held that altered protein binding meaningfully changes drug effect, but later analyses argued that for most drugs such changes have limited clinical consequence because compensating changes in clearance keep free-drug exposure relatively stable.
Key figures
- Malcolm Rowland
- Thomas Tozer
- Leslie Benet
Related topics
Seminal works
- rowland-tozer-2011
- benet-2002
- lombardo-2002
Frequently asked questions
- What does the distribution phase of pharmacokinetics describe?
- It describes how a drug, after entering the blood, moves reversibly into and out of the body's tissues; the extent of this movement is shaped by blood flow, membrane permeability, and binding to plasma proteins and tissues.
- Why does only the free drug matter for distribution and effect?
- Drug bound to plasma proteins or tissue cannot cross membranes or engage targets; only the unbound (free) fraction is available to distribute, act, and be eliminated, so binding equilibria determine effective exposure.